Iman Hassanally

Iman joins us as a recent graduate from the University of Cambridge, where she earned an MPhil in Bioscience Enterprise. She brings strategy experience spanning both early-stage start-ups and global biopharmaceutical companies; and has also previously worked as a clinical research associate researching a rare autoimmune liver disease. Her work led to a co-authored publication in Liver International on predicting treatment response in primary biliary cholangitis using early alkaline phosphatase biomarkers. Iman also holds an Honours Bachelor of Science in Human Physiology, Biology, and Health Studies from the University of Toronto.